The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

SKP SKYEPHARMA PLC ORD 100P




 Page 1 of 5

| 1 | 2 | 3 | 4 | 5 | Next

Time/Date Code Headline Source Impact
09:59 23-May-2016 SKP Form 8.3 - Skyepharma Plc BZN -0.61% Down
09:56 19-May-2016 SKP Form 8.3 - Skyepharma Plc BZN -0.06% Down
13:08 18-May-2016 SKP Result of AGM RNS -0.05% Down
07:00 18-May-2016 SKP Trading Statement RNS -0.05% Down
08:55 16-May-2016 SKP Form 8.3 - Skyepharma Plc BZN -0.07% Down
10:04 12-May-2016 SKP Form 8.3 - Skyepharma Plc BZN -0.40% Down
09:46 11-May-2016 SKP Form 8.3 - Skyepharma Plc BZN -0.29% Down
10:10 10-May-2016 SKP Form 8.3 - Skyepharma Plc BZN -0.14% Down
09:27 10-May-2016 SKP Form 8 (DD) - Peter Grant RNS -0.14% Down
09:25 10-May-2016 SKP Form 8 (DD) - Andrew Derodra RNS -0.14% Down
10:22 09-May-2016 SKP Form 8.3 - Skyepharma Plc BZN +0.13% Up
10:59 06-May-2016 SKP Director/PDMR Shareholding RNS +0.15% Up
15:08 05-May-2016 SKP Notice of Results RNS -0.39% Down
09:50 05-May-2016 SKP Form 8.3 - Skyepharma Plc BZN -0.39% Down
09:45 04-May-2016 SKP Form 8.3 - Skyepharma Plc BZN -1.01% Down
09:21 28-Apr-2016 SKP Form 8.3 - Skyepharma Plc BZN -1.37% Down
07:00 27-Apr-2016 SKP Holding(s) in Company RNS -0.76% Down
08:29 26-Apr-2016 SKP Form 8.3 - Skyepharma Plc BZN -0.30% Down
09:28 25-Apr-2016 SKP Form 8.3 - Skyepharma Plc BZN -0.06% Down
09:46 21-Apr-2016 SKP Form 8.3 - Skyepharma Plc BZN +0.27% Up

 Page 1 of 5

| 1 | 2 | 3 | 4 | 5 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Market

Company Information
Updated Monthly
Company address 46-48 Grosvenor Gardens, London, SW1W 0EB, United Kingdom
Company website http://www.skyepharma.c...
Market cap(in millions)* £ 483.18
Listing/Admission to trading 03 May 1996
Trading service SETS
Market MAINMARKET
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
29-May-16
FTSE index FTSE All-Share,FTSE SmallCap,FTSE techMARK Focus,FTSE SmallCap (ex IT),FTSE techMARK mediscience,FTSE techMARK All-Share,FTSE All-Share (ex IT)
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment SSMM
MiFID Status Regulated Market
Exchange market size 500
SEDOL B3BFNB6
ISIN number GB00B3BFNB64



SKYEPHARMA share news analysis (SKP)